0001796831-20-000001.txt : 20200929 0001796831-20-000001.hdr.sgml : 20200929 20200929160532 ACCESSION NUMBER: 0001796831-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200929 DATE AS OF CHANGE: 20200929 EFFECTIVENESS DATE: 20200929 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ingenia Therapeutics Inc. CENTRAL INDEX KEY: 0001796831 IRS NUMBER: 831818828 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-376621 FILM NUMBER: 201208922 BUSINESS ADDRESS: STREET 1: 650 EAST KENDALL STREET STREET 2: BIOLABS 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (781) 491-9005 MAIL ADDRESS: STREET 1: 650 EAST KENDALL STREET STREET 2: BIOLABS 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001796831 Ingenia Therapeutics Inc. 650 EAST KENDALL STREET BIOLABS 2ND FLOOR CAMBRIDGE MA MASSACHUSETTS 02142 (781) 491-9005 DELAWARE None None Corporation true 2018 Sangyeul Han c/o Ingenia Therapeutics 650 EAST KENDALL ST, BIOLABS 2ND FLOOR CAMBRIDGE MA MASSACHUSETTS 02142 Executive Officer Director Minji Kim c/o Ingenia Therapeutics 650 EAST KENDALL ST, BIOLABS 2ND FLOOR CAMBRIDGE MA MASSACHUSETTS 02142 Executive Officer Director Biotechnology Decline to Disclose 06b false 2020-09-25 false true false 0 5707530 4707530 1000000 false 9 0 0 0 false Ingenia Therapeutics Inc. /s/ Sangyeul Han Sangyeul Han President 2020-09-29